by Angela L. Huang | Oct 19, 2022 | News
SAN FRANCISCO, CA —Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived cell products and affiliated cell-based services in the following...
by Allison Kennedy | Feb 13, 2023 | Citation Alerts
Tempo-iKidneyPod™ was mentioned in springer.com in a review article that summarized various investigative methods and applications of microfluidic chips, specifically to examine how SARS-CoV-2 causes acute kidney injury (AKI). Tempo-iKidneyPod™ is composed of human...
by Olwen Reina | Mar 30, 2016 | Trends
Multiple Sclerosis (MS) is an inflammation-driven disease of the Central Nervous System (CNS). It is characterized by increased mononuclear cell infiltration of the CNS and autoimmune destruction of the myelin sheath of neurons resulting in distinct lesions/scarring...
by Olwen Reina | Aug 21, 2016 | Trends
A girl is laughing. She is sitting in the kitchen munching on peanuts, enjoying the cracking of the shells and joking with her sister. Her parents are relaxing nearby; all is well. Looking at the clock, the girl’s mother cautions that it’s late and the...
by Olwen Reina | Sep 21, 2016 | Trends
Epilepsy is a chronic neurological disorder defined by recurrent seizures. Previously, we discussed what seizures are including how they manifest and progress. We briefly examined the broad types of epilepsy based on where in the brain they started and whether or not...
